Author

Miriam Mañosa 1

1 Germa

ANP32E IS INVOLVED IN THE STEROID-REFRACTORY ULCERATIVE COLITIS

Violeta Loren, Juan Enrique Naves, F. Javier Carmona, EDUARD CABRE, Miriam Mañosa, Josep Manyé, Eugeni Domenech Morral

BENEFITS OF PAEDIATRIC TO ADULT TRANSITION PROGRAM IN INFLAMMATORY BOWEL DISEASE: THE BUTTERFLY STUDY OF GETECCU

Cristina Rubín de Célix, Javier Martín de Carpi, Gemma Pujol Muncunill, Laura María Palomino Pérez, Marta Velasco Rodríguez-Belvís, Rafael Martín-Masot, Victor Manuel Navas-López, Elena Ricart, María José Casanova, Alejandro Rodríguez Martínez, Eduardo Leo-Carnerero, Alba Alcaraz, Míriam Mañosa, Vicent Hernández, Romina Ferná

CAN HOSPITAL ADMISSIONS FOR LOWER GASTROINTESTINAL BLEEDING BE REDUCED? IMPLEMENTATION OF TWO SCALES FOR THE PREDICTION OF SAFETY DISCHARGE IN A RETROSPECTIVE COHORT

Laura Gonzalez Gonzalez, Ignacio Iborra, Marta Fortuny, ANNA CALM SALVANS, Fiorella Cañete, Margalida Calafat Sard, Míriam Mañosa, Eugeni Domenech Morral

CLINICAL DIFFERENTIAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) OF ONSET IN PEDIATRIC AGE COMPARED TO PATIENTS DIAGNOSED IN ADULTHOOD

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Valle García-Sánchez, Carlos Taxonera, Miriam Mañosa, Isabel Vera Mendoza, Miguel Mínguez, Federico Argüelles, Luisa de Castro, M Arroyo, Antonio López-Sanromán, Montserrat Rivero Tirado, Jordi Guardiola Capon, María Dolores Martín-Arranz, Belen Beltran, Jesús Barrio, Sabino

EFFECTIVENESS AND SAFETY OF THE SWITCH FROM REMICADE<sup>®</sup> TO CT-P13 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Maria Chaparro Sanchez, A Garre, Maria Fernanda Guerra Veloz, J M Vázquez, M L De Castro, Eduardo Leo Carnerero, E Rodríguez, A Y Carbajo, Sabino Riestra Menéndez, I Jiménez, Xavier Calvet Calvo, Luis Bujanda, Montserrat Rivero, Fernando Gomollón, Jose Manuel Benitez, Fernando Bermejo, Noelia Alcaide, Ana Gutierrez Casbas;

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASES

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Marisa Iborra, Francisco Mesonero Gismero, Maria Vera, Sabino Riestra Menéndez, V García-Sánchez, Luisa de Castro, A Martin-Cardona, Xavier Aldeguer, M Mínguez, Manuel Barreiro de-Acosta, Montserrat Rivero, F Muñoz, Montserrat Andreu, A Bargallo, E García-Planella, J. L. Pé

EVALUATION OF ADHERENCE TO INFLIXIMAB THERAPY IN IBD PATIENTS

Ariadna Clos, GIANCARLO CORRALES ROMERO, Fiorella Cañete, Triana Lobaton Ortega, macarena larrain, Laura Marin, Miriam Mañosa, EDUARD CABRE, Eugeni Domenech Morral

Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multicentre cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Sandra Marín Pedrosa, Marta Calvo, Francisco Rodriguez-Moranta, Carlos Taxonera Samso, Pilar Nos Mateu, Francisco Mesonero, Mariló Martin-Arranz, Miguel Mínguez, Javier Gisbert, Santiago López, Ruth De Francisco Garcia, Fernando Gomollón Garcia, Xavier Calvet, Esther Garc

LONG-TERM EVOLUTION AFTER ANTI-TNF DRUG DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

María José Casanova, Maria Chaparro, Oscar Nantes Castillejo, Jose Manuel Benitez, Maria Rojas-Feria, Jesus Castro Poceiro, J. M. Huguet-Malavés, Albert Martin-Cardona, M Aicart, Joan Tosca, MM Martín-Rodríguez, Carlos Gonzalez Muñoza, Miriam Mañosa, Eduardo Leo Carnerero, Luis Javier Lamuela-Calvo, Isabel Pérez-Martínez, L

LONG-TERM TRENDS IN TARGETED THERAPIES USAGE IN INFLAMMATORY BOWEL DISEASE: TRENDY STUDY OF ENEIDA

Celia Gomez Labrador, Elena Ricart, Marisa Iborra, Eva Iglesias, María Dolores Martín-Arranz, Luisa De Castro, Ruth María de Francisco García, Francisco Javier Garcia-Alonso, Ana Sanahuja Martínez, Carla J. Gargallo-Puyuelo, Francisco Mesonero, María José Casanova, Míriam Mañosa, Montserrat Rivero, Marta Calvo, Mónica Sierra

Item 1 - 10 / 19
1
2